OTCMKTS:MSSTF Mindset Pharma (MSSTF) Stock Price, News & Analysis $0.54 0.00 (0.00%) As of 10/27/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Mindset Pharma Stock (OTCMKTS:MSSTF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Mindset Pharma alerts:Sign Up Key Stats Today's Range$0.54▼$0.5450-Day Range$0.54▼$0.5452-Week Range$0.16▼$0.56VolumeN/AAverage Volume33,313 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.Read More… Receive MSSTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mindset Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address MSSTF Stock News HeadlinesMadrigal Pharmaceuticals: Looking To Finally Establish A Position Around The Q3 EarningsOctober 28, 2024 | seekingalpha.comCrispr Therapeutics: Poised For A Major TurnaroundOctober 28, 2024 | seekingalpha.comThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.June 17, 2025 | Priority Gold (Ad)Why Indian students should choose Ireland as their study-abroad destination: Expert answers your questionsOctober 17, 2024 | msn.comNews snapshot: LithiumBank, Minto Metals, Versus Systems, Mindset Pharma, PyroGenesis, Soma Gold UPDATE...October 16, 2024 | proactiveinvestors.com.auThese three market leading stocks can plunge if Kamala Harris wins US electionsOctober 10, 2024 | msn.comTranscript: The Futurist: What’s Next with AI?October 3, 2024 | washingtonpost.comCelestica: Institutional Investors Are Buying, So Am ISeptember 27, 2024 | seekingalpha.comSee More Headlines MSSTF Stock Analysis - Frequently Asked Questions How have MSSTF shares performed this year? Mindset Pharma's stock was trading at $0.5381 at the beginning of the year. Since then, MSSTF shares have increased by 0.0% and is now trading at $0.5381. View the best growth stocks for 2025 here. How do I buy shares of Mindset Pharma? Shares of MSSTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:MSSTF CIKN/A Webwww.mindsetpharma.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:MSSTF) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mindset Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mindset Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.